Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Novo Nordisk A/S
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
United States, Argentina, Australia, Belgium, Brazil +15 more
Sponsor: AstraZeneca
Chronic Kidney Disease With High Proteinuria
United States, Argentina, Australia, Austria, Brazil +25 more
Sponsor: Biogen
Immunoglobulin A Nephropathy (IgAN)
United States, Argentina, Australia, Belgium, Brazil +23 more
- Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell LymphomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Adult Nasal Type Extranodal NK/T-Cell Lymphoma · Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma · Recurrent Nasopharyngeal Undifferentiated Carcinoma · Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
United States, Hong Kong, Japan, Singapore
Sponsor: Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
Australia, China, France, Germany, Japan +2 more
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
Sponsor: Novartis Pharmaceuticals
Scleroderma, Diffuse
United States, Argentina, Australia, Austria, Belgium +17 more
Sponsor: UCB Biopharma SRL
Moderate to Severe Plaque Psoriasis
United States, Belgium, Canada, Czechia, Germany +5 more
Sponsor: AstraZeneca
Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin) · Renal Cell Carcinoma
United States, Australia, Japan, South Korea
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Active Not Recruiting
Sponsor: Swedish Orphan Biovitrum
VEXAS · VEXAS Syndrome
United States, Canada, France, Germany, Italy +3 more
- Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)Active Not Recruiting
Sponsor: GlaxoSmithKline
Systemic Lupus Erythematosus
United States, Argentina, Germany, Japan, Mexico +2 more
- A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsRecruiting
Sponsor: AstraZeneca
Untreated Follicular Lymphoma
United States, Australia, Belgium, Brazil, Canada +18 more
Sponsor: Taiho Pharmaceutical Co., Ltd.
RET-altered Non Small Cell Lung Cancer · RET-altered Solid Tumors
United States, Australia, Japan, South Korea
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Systemic Lupus Erythematosus (SLE)
China
Sponsor: AstraZeneca
B-cell Acute Lymphoblastic Leukemia (B-ALL)
United States, Australia, Brazil, Canada, China +8 more
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer (SCLC) · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
United States, Argentina, Australia, Austria, Belgium +37 more
Sponsor: Boston Scientific Corporation
Peripheral Vascular Diseases
United States, Australia, Austria, Canada, China +7 more
Sponsor: Novartis Pharmaceuticals
Dermatitis, Atopic
Japan
- Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A AdultsActive Not Recruiting
Sponsor: Pfizer
Hemophilia A
United States, Australia, Brazil, Canada, France +11 more
- Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive Not Recruiting
Sponsor: AstraZeneca
Ovarian Cancer · Breast Cancer · Pancreatic Cancer · Prostate Cancer
United States, Australia, Canada, China, Czechia +9 more
- PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717Active Not Recruiting
Sponsor: Ionis Pharmaceuticals, Inc.
Prion Disease
United States, Australia, Canada, France, Germany +4 more
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Argentina, Australia, China, France +11 more
- Global Open-Label Extension Study of Del-desiran for the Treatment of DM1Enrolling By Invitation
Sponsor: Avidity Biosciences, Inc.
Myotonic Dystrophy Type 1 · DM1 · Myotonic Dystrophy · Myotonia
United States, Canada, Denmark, France, Germany +5 more
- Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCRecruiting
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
United States, Australia, Brazil, China, Hong Kong +6 more
Sponsor: Boehringer Ingelheim
Extrapulmonary Neuroendocrine Cancer (epNEC)
United States, Argentina, Australia, Austria, Belgium +24 more